A phase I first in man study of Colony Stimulating factor-1 receptor inhibitor
Latest Information Update: 09 Feb 2024
At a glance
- Drugs Colony Stimulating factor 1 receptor inhibitor Myrobalan Therapeutics (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; First in man
- 09 Feb 2024 New trial record
- 07 Feb 2024 According to a Myrobalan Therapeutics media release, the company plans to start this study in 2025.